EAM
PRAX icon

Erste Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Erste Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Buy
12,200
+1,700
+16% +$538K 0.03% 306
2026
Q1 		$2.9M Hold
10,500
– – 0.03% 321
2025
Q4 		$3.2M Buy
+10,500
New +$1.96M 0.03% 308

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Erste Asset Management's PRAX Position: Q2 2026 in Review

Erste Asset Management increased its Praxis Precision Medicines (PRAX) stake by 16% in Q2 2026, buying an estimated $538K and bringing the position to 12,200 shares worth $4.28M. The position accounts for 0.03% of the portfolio, ranked #306.

Erste Asset Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Erste Asset Management held 12,200 shares of Praxis Precision Medicines worth $4.28M as of Q2 2026.
  • Erste Asset Management bought 1,700 Praxis Precision Medicines shares in Q2 2026, an estimated $538K.
  • Praxis Precision Medicines made up 0.03% of Erste Asset Management's portfolio in Q2 2026, its #306 holding.
  • Erste Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.